A roadmap from unknowns to knowns: Advancing our understanding of the microbiomes of commercially available tobacco products
Authors:
- 11 March 2021
- journal article
- review article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 105 (7) , 2633-2645
Abstract
Tobacco smoking is still the leading cause of preventable diseases and death in the USA and throughout the globe. Under Section 904(a)(3) of the US FederalKeywords
Funding Information
- Center for Tobacco Products (P50CA180523)
This publication has 63 references indexed in Scilit:
- The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of ExacerbationsPLOS ONE, 2012
- Effects of Subinhibitory Concentrations of Menthol on Adaptation, Morphological, and Gene Expression Changes in Enterohemorrhagic Escherichia coliApplied and Environmental Microbiology, 2012
- Cigarette Smoke, Bacteria, Mold, Microbial Toxins, and Chronic Lung InflammationJournal of Oncology, 2011
- Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPDPLOS ONE, 2011
- Human Pathogens Abundant in the Bacterial Metagenome of CigarettesEnvironmental Health Perspectives, 2010
- Tobacco Industry Control of Menthol in Cigarettes and Targeting of Adolescents and Young AdultsAmerican Journal of Public Health, 2008
- Identification of bacterial and fungal components in tobacco and tobacco smokeTobacco Induced Diseases, 2008
- Antimicrobial and antiplasmid activities of essential oilsFitoterapia, 2006
- Globicatella sanguis gen.nov., sp.nov., a new Gram‐positive catalase‐negative bacterium from human sourcesJournal of Applied Bacteriology, 1992
- Mycological flora of cigarettesMycopathologia, 1971